BPC-157 stimulates angiogenesis via the VEGF (Vascular Endothelial Growth Factor) and eNOS (endothelial nitric oxide synthase) pathways, increasing NO production, which promotes vasodilation and the formation of new capillaries
Medications: Address specific health issues or conditions with our range of equine medications, including antibiotics, pain relievers, and more
Component 1: BPC-157 Form: Lyophilized powder Purity: 98% (HPLC) Molecular Formula: CHNO Molecular Weight: 1419.5 g/mol Classification: Synthetic pentadecapeptide analog (15 amino acids) Structure Reference: Features a defined peptide chain frequently illustrated in analytical peptide modeling
overactivation of PARPs, such as during extensive genotoxic stress, can result in significant NAD + depletion and subsequent compromise of cellular energy homeostasis
However, full recovery timelines depend on the severity of injury and other healing factors (e.g., nutrition, sleep, training volume)